Mexico and Canada 
Outside North America 
US 
CAT #: 23080010
BCL1/JH Tube - Unlabeled for Gel Detection
Product Use
BCL1/JH Tube – Unlabeled for Gel Detection is a Research Use Only master mix that can be used to identify IGH-CCND1 (BCL1) translocations.
Product Details
-
Description
The aberrant BCL1/JH t(11;14) translocation juxtaposes genes of the immunoglobulin heavy chain (IGH) gene on chromosome 14q32 with the cyclin D1 gene on chromosome 11q13. The juxtaposition of IGH-sequences results in the transcriptional activation of cyclin D1.1,2 Cyclin D1 is involved in the regulation of the G1 progression and G1/S transition of the cell cycle.3 Translocation does not lead to expression of a fusion protein. In fact, oncogenesis is due to a promoter/enhancer exchange, wherein the immunoglobulin gene enhancer stimulates the expression of cyclin D1. Overexpression of cyclin D1, in turn, accelerates passage of transformed cells through the G1 phase.
The BCL1/JH Tube master mix targets the major translocation cluster (MTC) of the BCL1 and IG heavy chain locus. PCR products can be analyzed using standard gel electrophoresis using heteroduplex analysis with ethidium staining.
References
1. van Dongen, JJM, et. al., (2003). Leukemia. 17(12):2257-2317.
2. Janssen, J.W.G., et. al., (2000). Blood. 95:2691-2698.
3. Shimazaki C, et. al., (1997). International Journal of Hematology. 66(1):111-5.
Legal Notice
Warranty and Liability
Invivoscribe, Inc. (Invivoscribe®) is committed to providing the highest quality products. Invivoscribe® warrants that the products meet or exceed the performance standards described in the Instructions For Use, as to products with such an insert. If a product is covered by product specifications and does not perform as specified, our policy is to replace the product or credit the full purchase price. No other warranties of any kind, expressed or implied, are provided by Invivoscribe®. Invivoscribe® liability shall not exceed the purchase price of the product. Invivoscribe® shall have no liability for direct, indirect, consequential or incidental damages arising from the use, results of use, or inability to use its products; product efficacy under purchaser controlled conditions in purchaser’s laboratory must be established and continually monitored through purchaser defined and controlled processes including but not limited to testing of internally validated positive, negative, and blank controls every time a sample is tested. Ordering, acceptance and use of product constitutes purchaser acceptance of sole responsibility for assuring product efficacy and purchaser agreement to the limitation of liability set forth in this paragraph.
This product is for Research Use Only; not for use in diagnostic procedures.
©2020 Invivoscribe, Inc. All rights reserved. The trademarks mentioned herein are the property of Invivoscribe, Inc. and/or its affiliates, or (as to the trademarks of others used herein) their respective owners.